Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Relevium Technologies Inc V.RLV.H

Alternate Symbol(s):  RLLVF

Relevium Technologies Inc. is a Canada-based company, which operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets with a focus on e-commerce. The Company operates through two wholly owned subsidiaries, BGX E-Health LLC and Biocannabix Health Corporation Inc. BGX E-Health LLC markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals, primarily through its Bioganix brand portfolio online in the United States. It provides a Push & Pull System by Bioganix. Push & Pull System is a comprehensive natural anti-aging system for complete skin care that combines collagen protein supplements (PUSH) and naturally sourced aloe vera skin anti-aging cream (PULL).


TSXV:RLV.H - Post by User

Post by user46on Sep 22, 2022 11:28am
137 Views
Post# 34979087

Linked or not???????

Linked or not???????Looking forward if it's linked together.................????????? From news April 2022: "The partnership between BCX and IAM was designed to provide continuity to the research the company began in the pediatric cannabinoid space and will leverage the clinical and research capabilities both in Germany and Colombia through its investment in Lifeline Pharma for Nutraceutical and Pharmaceutical development" AND https://www.google.ca/amp/s/www.cannabisandhempinsider.com/amp/a-conversation-with-management-of-german-cbd-manufacturer-iam-health-and-swiss-based-novera-partners Good Luck to all shareholders!
<< Previous
Bullboard Posts
Next >>